DTC (Direct to Consumer) 検査産業：世界市場

世界のDTC (Direct to Consumer) 検査の市場規模は、2023年の16億米ドルから、予測期間中はCAGR 12.5%で推移し、2029年には32億米ドルに達すると予測されています。

遺伝子DTC検査の部門は、2023年の13億米ドルから、CAGR 12.7％で推移し、2029年には27億米ドルに達すると予測されています。また、マイクロバイオームDTC検査の部門は、2023年の513億米ドルから、CAGR 13.7%で推移し、2029年には1,095億米ドルに達すると予測されています。

当レポートでは、世界のDTC (Direct to Consumer) 検査の市場を調査し、市場概要、市場影響因子および市場機会の分析、新興技術および技術開発の動向、特許動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• PESTEL分析
• ポーターのファイブフォース分析
• 業界における競合
• 規制状況
• 米国
• 欧州
• アジア太平洋
• その他の地域

第3章 市場力学

• 市場力学
• 市場促進要因
• 消費者と医師の意識の高まり
• 遺伝子配列解析のコストの低下
• 市場抑制要因
• 規制ガイドラインの欠如
• 結果の不正確さ
• 市場機会
• 新興経済国
• 市場の課題
• 倫理とデータプライバシーの問題

第4章 新興技術と開発

• 新技術
• 遺伝子配列解析の進歩
• デジタル化
• AI
• 特許分析
• 特許：企業別

第5章 市場セグメンテーション分析

• セグメント別内訳
• 市場分析：検査タイプ別
• 遺伝子DTC検査
• バイオマーカーベースDTC検査
• マイクロバイオームDTC検査
• 市場分析：用途別
• 健康・ウェルネス
• 祖先・系譜
• 疾病リスク評価
• キャリアスクリーニング
• 薬理遺伝学的検査
• 全ゲノム配列に基づくDTC検査
• その他
• 市場分析：流通チャネル別
• オンライン
• 小売
• 地理的内訳
• 市場分析：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 市場分析
• 主要企業
• 戦略分析

第7章 DTC (Direct to Consumer) 検査における持続可能性：ESGの観点

• ESG：概要
• DTC検査業界における持続可能性：ESGの観点
• 主要なESG上の問題
• DTC検査業界のESGパフォーマンス分析
• BCCによる総論

第8章 付録

• 調査手法
• 出典
• 頭字語
• 企業プロファイル
• 23ANDME INC.
• ANCESTRY
• GENETIC TECHNOLOGIES LTD.
• EVERLYWELL INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• MAPMYGENOME
• MICROBIOME LABS
• MYHERITAGE LTD.
• QUEST DIAGNOSTICS INC.
• VIOME LIFE SCIENCES INC.

List of Tables

• Summary Table : Global Market for DTC Testing, by Test Type, Through 2029
• Table 1 : Comparison: DTC tests v/s Traditional Medical Tests
• Table 2 : FDA Regulation of DTC Tests
• Table 3 : DTC Genetic Tests: Ethical Issues
• Table 4 : Patents, by Top Companies, 2022-2024
• Table 5 : Global Market for DTC Testing, by Test Type, Through 2029
• Table 6 : Global Market for Genetic DTC Tests, by Region, Through 2029
• Table 7 : Global Market for Biomarker-based DTC Tests, by Region, Through 2029
• Table 8 : Global Market for Microbiome DTC Tests, by Region, Through 2029
• Table 9 : Global Market for DTC Testing, by Application, Through 2029
• Table 10 : List of DTC Tests for Health and Wellness
• Table 11 : Global Market for Health and Wellness DTC Testing, by Region, Through 2029
• Table 12 : DTC Ancestry and Genealogy Tests
• Table 13 : Global Market for Ancestry and Genealogy DTC Testing, by Region, Through 2029
• Table 14 : Global Market for Disease Risk Assessment in DTC Testing, by Region, Through 2029
• Table 15 : Global Market for Carrier Screening in DTC Testing, by Region, Through 2029
• Table 16 : Global Market for Pharmacogenetic DTC Testing, by Region, Through 2029
• Table 17 : List of WGS-based DTC Testing Companies, as of February 2022
• Table 18 : Global Market for Whole Genome Sequence-based DTC Testing, by Region, Through 2029
• Table 19 : Global Market for Other DTC Tests, by Region, Through 2029
• Table 20 : Global Market for DTC Testing, by Distribution Channel, Through 2029
• Table 21 : List of Some DTC Tests Available on Amazon
• Table 22 : Global Market for Online Channel for DTC Testing, by Region, Through 2029
• Table 23 : Global Market for Retail Channels for DTC Testing, by Region, Through 2029
• Table 24 : Global Market for DTC Testing, by Region, Through 2029
• Table 25 : DTC Testing: Market Player Share Analysis, 2023
• Table 26 : Direct-to-Consumer Testing: Recent Developments, 2024
• Table 27 : ESG Rankings for DTC Testing Companies, 2024*
• Table 28 : ESG: Environmental Overview
• Table 29 : ESG: Social Overview
• Table 30 : ESG: Governance Overview
• Table 31 : Report Sources
• Table 32 : Glossary of Terms Used in Direct-to-Consumer Testing Market
• Table 33 : 23andMe Inc.: Company Snapshot
• Table 34 : 23andMe Inc.: Financial Performance, FY 2022 and 2023
• Table 35 : 23andMe Inc.: Product Portfolio
• Table 36 : 23andMe Inc.: News/Key Developments, 2021-2023
• Table 37 : Ancestry: Company Snapshot
• Table 38 : Ancestry: Product Portfolio
• Table 39 : Ancestry: News/Key Developments, 2021-2023
• Table 40 : Genetic Technologies Ltd.: Company Snapshot
• Table 41 : Genetic Technologies Ltd.: Financial Performance, FY 2022 and 2023
• Table 42 : Genetic Technologies Ltd.: Product Portfolio
• Table 43 : Genetic Technologies Ltd.: News/Key Developments, 2021-2023
• Table 44 : Everlywell Inc.: Company Snapshot
• Table 45 : Everlywell Inc.: Product Portfolio
• Table 46 : Laboratory Corporation of America Holdings: Company Snapshot
• Table 47 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
• Table 48 : Laboratory Corporation of America Holdings: Product Portfolio
• Table 49 : Laboratory Corporation of America Holdings: News/Key Developments, 2023
• Table 50 : MapmyGenome: Company Snapshot
• Table 51 : MapmyGenome: Product Portfolio
• Table 52 : Microbiome Labs: Company Snapshot
• Table 53 : Microbiome Labs: Product Portfolio
• Table 54 : MyHeritage Ltd.: Company Snapshot
• Table 55 : MyHeritage Ltd.: Product Portfolio
• Table 56 : Quest Diagnostics Inc.: Company Snapshot
• Table 57 : Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
• Table 58 : Quest Diagnostics Inc.: Product Portfolio
• Table 59 : Quest Diagnostics Inc.: News/Key Developments, 2022-2023
• Table 60 : Viome Life Sciences Inc.: Company Snapshot
• Table 61 : Viome Life Sciences Inc.: Product Portfolio
• Table 62 : Viome Life Sciences Inc.: News/Key Developments, 2022

List of Figures

• Summary Figure : Global Market for DTC Testing, by Test Type, 2021-2029
• Figure 1 : DTC Testing: Types
• Figure 2 : DTC Testing: Advantages and Disadvantages
• Figure 3 : DTC Testing: PESTEL Analysis
• Figure 4 : Market Dynamics of DTC Testing
• Figure 5 : Cost Per Genome, November 2017-May 2022
• Figure 6 : Emerging Trends/Technologies in the DTC Testing Market
• Figure 7 : Global Market Shares for DTC Testing, by Test Type, 2023
• Figure 8 : Global Market Shares for DTC Testing, by Application, 2023
• Figure 9 : Types of Genetic Ancestry Testing
• Figure 10 : Global Market Shares for DTC Testing, by Distribution Channel, 2023
• Figure 11 : Global Market Shares for DTC Testing, by Region, 2023
• Figure 12 : North American Market for DTC Testing, 2021-2029
• Figure 13 : European Market for DTC Testing, 2021-2029
• Figure 14 : Asia-Pacific Market for DTC Testing, 2021-2029
• Figure 15 : Rest of the World Market for DTC Testing, 2021-2029
• Figure 16 : DTC: Market Player Share Analysis, 2023
• Figure 17 : DTC Testing: Recent Developments, by Category, 2024
• Figure 18 : ESG Pillars
• Figure 19 : Advantages of ESG for Companies
• Figure 20 : ESG Penetration, DTC Testing Market, 2024
• Figure 21 : Methodology Used in Direct-to-Consumer Testing Market
• Figure 22 : 23andMe Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 23 : 23andMe Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 24 : Genetic Technologies Ltd.: Revenue Shares, by Business Unit, FY 2023
• Figure 25 : Genetic Technologies Ltd.: Revenue Shares, by Country/Region, FY 2023
• Figure 26 : Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
• Figure 27 : Quest Diagnostics Inc.: Revenue Shares, by Business Unit, FY 2023

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

The genetic DTC tests market for DTC testing is estimated to increase from $1.3 billion in 2023 to reach $2.7 billion by 2029, at a CAGR of 12.7% from 2024 through 2029.

The microbiome DTC tests market for DTC testing is estimated to increase from $51.3 billion in 2023 to reach $109.5 billion by 2029, at a CAGR of 13.7% from 2024 through 2029.

Report Scope

The current report provides detailed information about the direct-to-consumer (DTC) testing market. The report provides market projections for 2029 and market share for key market players. It details the market size of DTC testing based on test types, applications and distribution channels. Based on the test type, the DTC testing market is segmented into genetic DTC tests, biomarker-based DTC tests and microbiome DTC tests. The report excludes at-home pregnancy tests, fertility tests and COVID-19 tests. Provider-dependent at-home tests also are not included in this report. The report is segmented into health and wellness testing, ancestry and genealogy testing, carrier screening, disease risk assessment, pharmacogenetic testing, whole genome sequence-based DTC testing and other DTC tests based on application. Based on the distribution channel, the market is categorized into online and retail.

Report Includes

• 21 data tables and 42 additional tables
• Analysis of the global market landscape of direct-to-consumer (DTC) testing industry
• Analyses of the global market trends, with market revenue data for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects, along with a market share analysis by test type, application, distribution channel and region
• Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
• An analysis of patents related to DTC
• Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
• An analysis of the industry structure, including companies' market shares, M&A activity, and venture funding
• Company profiles of major players within the industry, including Ancestry, 23andMe Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., and MyHeritage Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• PESTEL Analysis
• Porter's 5 Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential of New Entrants
• Threat of Substitutes
• Competition in the Industry
• Regulatory Landscape
• U.S.
• Europe
• Asia-Pacific
• Rest of the World

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Consumer and Physician Awareness
• Decreasing Costs of Genetic Sequencing
• Market Restraints
• Lack of Regulatory Guidelines
• Inaccuracy of Results
• Market Opportunities
• Emerging Economies
• Market Challenges
• Ethical and Data Privacy Issues

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies
• Advances in Gene Sequencing
• Digitalization
• Artificial Intelligence
• Patent Analysis
• Patents, by Company

Chapter 5 Market Segmentation Analysis

• Segmental Breakdown
• Market Analysis, by Test Type
• Genetic DTC Tests
• Biomarker-based DTC Tests
• Microbiome DTC Tests
• Market Breakdown, by Application
• Health and Wellness Testing
• Ancestry and Genealogy Testing
• Disease Risk Assessment
• Carrier Screening
• Pharmacogenetic Testing
• Whole Genome Sequence-based DTC Testing
• Other DTC Tests
• Market Breakdown, by Distribution Channel
• Online Channel
• Retail Channels
• Geographic Breakdown
• Market Analysis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Market Analysis
• Top Players
• Strategic Analysis

Chapter 7 Sustainability in Direct-to-Consumer Testing: ESG Perspective

• Introduction to ESG
• Sustainability in Direct-to-Consumer (DTC) Testing Industry: An ESG Perspective
• Key ESG Issues
• DTC Testing Industry ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• 23ANDME INC.
• ANCESTRY
• GENETIC TECHNOLOGIES LTD.
• EVERLYWELL INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• MAPMYGENOME
• MICROBIOME LABS
• MYHERITAGE LTD.
• QUEST DIAGNOSTICS INC.
• VIOME LIFE SCIENCES INC.